Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, June 5, 2024
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Patrick Trucchio Reiterated (VIR) at Strong Buy and Held Target at $110 on, Jun 5th, 2024
Patrick Trucchio of HC Wainwright & Co., Reiterated "Vir Biotechnology, Inc." (VIR) at Strong Buy and Held Target at $110 on, Jun 5th, 2024.
Patrick has made no other calls on VIR in the last 4 months.
There is 1 other peer that has a rating on VIR. Out of the 1 peers that are also analyzing VIR, all agrees with Patrick's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Eric Joseph of "JP Morgan" Maintained at Hold with Increased Target to $12 on, Friday, May 3rd, 2024
